Silencing of cystatin M in metastatic oral cancer cell line MDA-686Ln by siRNA increases cysteine proteinases and legumain activities, cell proliferation and in vitro invasion
- 18 January 2006
- journal article
- Published by Elsevier in Life Sciences
- Vol. 78 (8), 898-907
- https://doi.org/10.1016/j.lfs.2005.05.096
Abstract
No abstract availableKeywords
This publication has 31 references indexed in Scilit:
- Evidence that unrestricted legumain activity is involved in disturbed epidermal cornification in cystatin M/E deficient miceHuman Molecular Genetics, 2004
- Cystatin M suppresses the malignant phenotype of human MDA-MB-435S cellsOncogene, 2003
- Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2−ΔΔCT MethodMethods, 2001
- Cystatin M/E Expression is Restricted to Differentiated Epidermal Keratinocytes and Sweat Glands: a New Skin-Specific Proteinase Inhibitor that is a Target for Cross-Linking by TransglutaminaseJournal of Investigative Dermatology, 2001
- Role of Transforming Growth Factor β in Human DiseaseNew England Journal of Medicine, 2000
- TGF-β1 inhibition of apoptosis through the transcriptional up-regulation of Bcl-X(L) in human monocytic leukemia U937 cellsExperimental & Molecular Medicine, 1999
- Assignment of a novel cysteine proteinase inhibitor (CST6) to 11q13 by fluorescence in situ hybridizationCytogenetic and Genome Research, 1997
- Cystatin C (CST3), the Candidate Gene for Hereditary Cystatin C Amyloid Angiopathy (HCCAA), and Other Members of the Cystatin Gene Family Are Clustered on Chromosome 20p11.2Genomics, 1993
- The cystatins: Protein inhibitors of cysteine proteinasesFEBS Letters, 1991
- Novel epoxysuccinyl peptides Selective inhibitors of cathepsin B, in vitroFEBS Letters, 1991